Marek Kultys
About Marek Kultys
Marek Kultys is the Director of UX at BenevolentAI in London, with extensive experience in product design and leadership roles across various companies in the UK.
Current Position: Director of UX at BenevolentAI
Marek Kultys currently serves as the Director of UX at BenevolentAI, located in London, England, United Kingdom. Marek's role involves leading the user experience design, focusing on enhancing the interaction between users and the AI-driven drug discovery platform.
Professional Experience in UX and Product Design
Marek Kultys has a robust background in UX and product design, highlighted by several key roles. At BenevolentAI, he advanced from Senior Product Designer to Lead Product Designer, and now holds the Director of UX position. Before BenevolentAI, he worked at Science Practice and Ctrl Group Ltd, contributing significantly as a Lead Designer. He also had a crucial role as Chief Product Officer at Bento Bio.
Educational Background
Marek Kultys holds a Master of Arts (MA) from Central Saint Martins, University of the Arts London, which he earned between 2009 and 2011. Additionally, he has a Bachelor of Arts (BA) from Akademia Sztuk Pięknych w Warszawie, completed between 2004 and 2008. His educational journey also includes studying at Zürcher Hochschule der Künste and attending the EBI Bioinformatics Summer School.
Key Contributions and Projects
Among his notable contributions, Marek Kultys led early design work for Bento Lab, a portable DNA research lab. He also played a role in defining the Longitude Prize 2014, a challenge focused on tackling antimicrobial resistance. His expertise spans designing products for clinical decision-making, reporting, and developing tools for biomedical data visualization and clinical trial management.
Public Speaking and Mentoring
Marek Kultys is active in the design community, regularly speaking at conferences and running design workshops. He serves as a mentor for aspiring designers and frequently writes about various design topics. His work and insights, particularly in the context of designing AI platforms for drug discovery, have been featured in videos and other media.